Apollomics (APLM) Total Current Liabilities (2021 - 2025)
Apollomics (APLM) posted quarterly Total Current Liabilities of $388000.0 for Q4 2025, down 99.32% quarter-over-quarter from $57.2 million in Q2 2023.
Apollomics (APLM) Total Current Liabilities (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Total Current Liabilities for 4 consecutive years, with $388000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities changed N/A year-over-year to $388000.0; the TTM figure through Dec 2025 stood at $388000.0 (changed N/A YoY), while the FY2025 annual figure was $388000.0, changed N/A from the prior year.
- Total Current Liabilities declined to $388000.0 in Q4 2025 per APLM's latest filing, from $57.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $64.1 million in Q4 2022 and bottomed at $388000.0 in Q4 2025.
- Historically, Total Current Liabilities has averaged $33.8 million across 4 years, with a median of $35.4 million in 2021.
- On a YoY basis, Total Current Liabilities climbed as much as 372.99% in 2022 and fell as far as 372.99% in 2022.
- Apollomics' Total Current Liabilities stood at $13.6 million in 2021, then jumped by 372.99% to $64.1 million in 2022, then fell by 10.72% to $57.2 million in 2023, then plunged by 99.32% to $388000.0 in 2025.
- Business Quant data shows APLM's Total Current Liabilities at $388000.0 in Q4 2025, $57.2 million in Q2 2023, and $64.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Apollomics | 34.08 Mn | 30.81 Mn | - | 388,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 388,000.00 |
| Jun 30, 2023 | 57.24 Mn |
| Dec 31, 2022 | 64.12 Mn |
| Dec 31, 2021 | 13.56 Mn |